$12.15
-$0.90
(-6.90%)
Quote as of 3:59 PM EST on 02/10/12
Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY
Extended Hours:
$12.15
$0.00
(0.00%)
Quote as of 5:15 PM EST on 02/10/12 (NASDAQ)
|
$12.15
-$0.90
(-6.90%)
|
|
| Today's Open | $12.60 |
|---|---|
| Previous Close | $13.05 |
| Daily Range | $11.72 - $12.79 |
| 52-Week Range | $5.88 - $13.25 |
| Market Cap | $519.13M |
| P/E Ratio | -10.97 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 722,456 |
| Average Daily Volume | 380,382 |
| Current FY EPS | -$1.35 |
ALNY Information
| Description |
|---|
| A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes. |
| Sector |
| Healthcare |
| Industry |
| Biotechnology |
News & Commentary
Alnylam Pharmaceuticals Shares Dropped: What You Need to Know
Alnylam Gets New Patent - Analyst Blog
Alnylam to Cut 33% Jobs - Analyst Blog
US STOCK FUTURES: HOT STOCKS TO WATCH
Alnylam Down to Neutral - Analyst Blog
Alnylam States Preclinical Data - Analyst Blog
Still Bullish on Alnylam - Analyst Blog
Alnylam Completes Trial Enrollment - Analyst Blog
Alnylam Reveals ALNTTR01 Trial Data - Analyst Blog
Sanofi, Regeneron's Anti-Cholesterol Drug Has Good Test Results
